Immix Biopharma will present interim clinical trial results of its NXC-201 CAR-T therapy for relapsed/refractory AL amyloidosis at the ASH 2026 meeting on December 14. The data comes from the NEXICART-2 trial, the first U.S. trial of CAR-T treatment for this rare and serious disease, which causes toxic protein buildup in organs. AL amyloidosis affects over 30,000 U.S. patients with a growing market valued at $6.6 billion in 2026. NXC-201 has received multiple FDA designations, highlighting its potential as a breakthrough therapy. This presentation could advance treatment options for patients with limited alternatives.
Immix Biopharma’s NXC-201 CAR-T therapy clinical trial results are highlighted here with Pluang’s health sector market data for context. As of Nov 04, 2026 20:41 WIB, 127 of 150 priced US health stocks rose while 19 fell. Notable movers include CVS Health Corp at USD 86.90 with a 4.93% decline and 91% buy order activity, Tilray Brands Inc at USD 2.78 with a 4.91% gain but 96% sell orders, and Alcon AG at USD 75.51 with a 4.34% increase and 91% sell orders. This snapshot offers insight into market dynamics on Pluang’s platform.
Kelly Technology + Motion Recruitment, a division of Kelly Services, has been recognized as a Leader on Everest Group's 2026 U.S. IT Contingent Talent and Strategic Solutions PEAK Matrix® for its expertise in specialized IT staffing, consulting, and ...
Sutro Biopharma, a clinical-stage oncology company specializing in antibody drug conjugates (ADCs), announced its participation in several investor conferences in November and December 2026, including events hosted by Stifel, Truist Securities, UBS, ...
etoro has agreed to acquire LB Finanzas, a leading Argentine all-in-one financial app, to strengthen its presence in Latin America's fast-growing fintech market. LB Finanzas offers integrated investing and payment solutions, catering to Argentine ret...
JD.com announced it will publish its unaudited financial results for the third quarter of 2026 on November 17, before the U.S. market opens. The company's management will hold a conference call the same day to discuss the results, providing investors...
KE Holdings Inc., a major online and offline housing platform in China, will announce its unaudited financial results for the third quarter of 2026 on November 16 before the U.S. market opens. The company will host an earnings conference call at 7:00...
